CPHI Webinar Series

Why the Excipients Market Needs to Embrace the New Normal

31st August 2022
4pm CET / 10am EST
What will this webinar address?

As with many segments of the industry, the pandemic has disrupted the excipients market and changed ways of working forever. Now, the industry needs to adopt a ‘new normal’ with regards to auditing, supply chain and regulatory processes to avoid stagnation and ensure future growth.

This webinar will provide an overview of the challenges and opportunities in the post-pandemic excipients market. Expert speakers will cover dynamics affecting auditing, regulation and supply chain issues; while highlighting key learnings from the last two years.

Key discussion points include:

  • Why we shouldn’t expect the market to return to its pre-pandemic status and how the industry should alter the approach
  • Assessing the existing auditing setup (hybrid vs on-site). What framework is required to ensure success and stability?
  • Debating current issues facing regulators in the post-pandemic set-up and exploring potential adjustments and solutions
  • Assessing potential bottle necks impacting the excipient supply chain, what can be done to ease tension?
  • Kevin Hughes
    Regulatory Affairs and QA Manager
    Colorcon and Board Member, IPEC Europe asbl

    Kevin has been with Colorcon for over 15 years where he has been the Technical Expert in film coating, immediate release excipients and extended release excipients. Kevin is now Regulatory Affairs and Quality Assurance Manager for Colorcon and is responsible for the EMEA region, providing regulatory support to customers in both the pharmaceutical and food industries, monitoring any regulatory changes, industry initiatives and is closely involved with the IPEC Quality and Regulatory Affairs Committee. Kevin is also responsible for Quality at the Dartford site, and hosting of all customer and certification audits as well as conducting supplier audits as an IRCA qualified Lead Auditor. Prior to Colorcon, Kevin spent 5 years at Boots Healthcare Development, where he was Team Leader developing solid oral dosage forms for Boots Pharmacies. Kevin graduated with from Nottingham University in 1994. He has been involved in the pharmaceutical industry for 20 years. .

    Dr. Iain Moore
    Head of Global Quality Assurance
    CRODA and President, EXCiPACT asbl

    Dr Iain Moore is the Global Head of Quality Assurance at Croda International, a supplier of many types of high purity excipients. He has held a range of QA roles in Croda for over 25 years, including implementing ISO and GMP standards and hosting regulatory inspections to API GMPs. He has contributed to the publication of both European and US National Standards, the famous IPEC-PQG GMP Guide for Pharmaceutical Excipients and the EFfCI GMP Guide for Cosmetic Ingredients. He was instrumental in the team that took the IPEC-PQG GMP Guide and converted it to the EXCiPACT Certification Scheme for Pharmaceutical Excipients. He is the current chair of the EFFCI GMP Committee and is the current President of the Board of EXCIPACT asbl. .

    This webinar is brought to you by
    Why the Excipients Market Needs to Embrace the New Normal
    • 31st August, 2022
    • 4pm CET / 10am EST
    • 60 minutes
    • Free
    CPHI Newsletter

    Get the latest from CPHI in your inbox every week.

    You understand that your information will be used in accordance with our Privacy Policy, and that you may withdraw your permission to receive any of our communications at any time by clicking on the Unsubscribe link in the Newsletters or opting out on our unsubscribe page page.